Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Long-Term Debt Repayments (2016 - 2020)

Historic Long-Term Debt Repayments for Larimar Therapeutics (LRMR) over the last 5 years, with Q1 2020 value amounting to $1.8 million.

  • Larimar Therapeutics' Long-Term Debt Repayments changed N/A to $1.8 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2019, which is N/A changed from last year.
  • As of Q1 2020, Larimar Therapeutics' Long-Term Debt Repayments stood at $1.8 million.
  • In the past 5 years, Larimar Therapeutics' Long-Term Debt Repayments registered a high of $1.8 million during Q4 2019, and its lowest value of $712000.0 during Q1 2016.
  • Moreover, its 4-year median value for Long-Term Debt Repayments was $787000.0 (2017), whereas its average is $1.1 million.
  • Data for Larimar Therapeutics' Long-Term Debt Repayments shows a peak YoY increase of 6798.94% (in 2017) and a maximum YoY decrease of 840.22% (in 2017) over the last 5 years.
  • Quarter analysis of 4 years shows Larimar Therapeutics' Long-Term Debt Repayments stood at $756000.0 in 2016, then soared by 67.99% to $1.3 million in 2017, then surged by 43.23% to $1.8 million in 2019, then fell by 0.05% to $1.8 million in 2020.
  • Its Long-Term Debt Repayments was $1.8 million in Q1 2020, compared to $1.8 million in Q4 2019 and $1.8 million in Q3 2019.